share_log

Truist Securities Maintains Hold on Fresenius Medical Care, Raises Price Target to $26

Truist Securities Maintains Hold on Fresenius Medical Care, Raises Price Target to $26

Truist Securities维持对费森尤斯医疗的持有,将目标股价上调至26美元
Benzinga ·  2023/05/10 09:20

Truist Securities analyst David Macdonald maintains Fresenius Medical Care (NYSE:FMS) with a Hold and raises the price target from $24 to $26.

Truist Securities分析师戴维·麦克唐纳维持费森尤斯医疗保健(纽约证券交易所代码:FMS)的持仓,并将目标股价从24美元上调至26美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发